Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Prima Biomed Ltd (PBMD)

Prima Biomed Ltd (PBMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Prima Biomed Ltd LEVEL 12 95 PITT STREET SYDNEY C3 2000 AUS

www.primabiomed.com.au P: 61-2-8315-7003

Description:

Prima Biomed Ltd is a biotechnology company focused on developing oncology therapies in the field of immunotherapy. The Company's key product candidates in development include CVac, an autologous dendritic cell vaccine for ovarian cancer, monoclonal antibodies for multiple tumor types, and an oral formulation for the Human Papilloma Virus. Prima Biomed Ltd is based in Sydney, Australia.

Key Statistics

Overview:

Market Capitalization, $K 40,065
Shares Outstanding, K 23,430
Annual Sales, $ 3,180 K
Annual Net Income, $ -7,060 K
60-Month Beta 1.25
% of Institutional Shareholders 0.54%

Growth:

1-Year Return -37.44%
3-Year Return -44.84%
5-Year Return -87.11%
5-Year Revenue Growth 15,800.00%
5-Year Earnings Growth -82.74%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 09/13/17
Earnings Per Share ttm 0.00
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 3-10 on 12/28/16

PBMD Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % -222.01%
Debt/Equity 0.22
Price/Sales 12.66
Price/Cash Flow N/A
Price/Book 2.00
Book Value/Share 0.85
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar